Laura Prendergast
Stock Analyst at Stifel
(5.00)
# 112
Out of 5,182 analysts
21
Total ratings
55.56%
Success rate
108.24%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Laura Prendergast
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TNGX Tango Therapeutics | Maintains: Buy | $24 → $40 | $26.33 | +51.92% | 3 | Apr 27, 2026 | |
| ERAS Erasca | Maintains: Buy | $20 → $30 | $19.15 | +56.66% | 3 | Apr 27, 2026 | |
| RVMD Revolution Medicines | Reiterates: Buy | $170 → $215 | $131.67 | +63.29% | 5 | Apr 20, 2026 | |
| OLMA Olema Pharmaceuticals | Initiates: Buy | $48 | $15.29 | +213.93% | 1 | Feb 11, 2026 | |
| BBOT BridgeBio Oncology Therapeutics | Initiates: Buy | $23 | $8.79 | +161.66% | 1 | Feb 11, 2026 | |
| FHTX Foghorn Therapeutics | Initiates: Buy | $12 | $5.21 | +130.33% | 1 | Dec 4, 2025 | |
| NUVL Nuvalent | Maintains: Buy | $115 → $135 | $104.04 | +29.76% | 2 | Nov 17, 2025 | |
| BDTX Black Diamond Therapeutics | Reinstates: Buy | $8 | $2.92 | +173.97% | 2 | Oct 16, 2025 | |
| COGT Cogent Biosciences | Initiates: Hold | $16 | $36.61 | -56.29% | 1 | Oct 16, 2025 | |
| NKTX Nkarta | Upgrades: Strong Buy | $16 | $2.83 | +465.37% | 2 | Aug 14, 2024 |
Tango Therapeutics
Apr 27, 2026
Maintains: Buy
Price Target: $24 → $40
Current: $26.33
Upside: +51.92%
Erasca
Apr 27, 2026
Maintains: Buy
Price Target: $20 → $30
Current: $19.15
Upside: +56.66%
Revolution Medicines
Apr 20, 2026
Reiterates: Buy
Price Target: $170 → $215
Current: $131.67
Upside: +63.29%
Olema Pharmaceuticals
Feb 11, 2026
Initiates: Buy
Price Target: $48
Current: $15.29
Upside: +213.93%
BridgeBio Oncology Therapeutics
Feb 11, 2026
Initiates: Buy
Price Target: $23
Current: $8.79
Upside: +161.66%
Foghorn Therapeutics
Dec 4, 2025
Initiates: Buy
Price Target: $12
Current: $5.21
Upside: +130.33%
Nuvalent
Nov 17, 2025
Maintains: Buy
Price Target: $115 → $135
Current: $104.04
Upside: +29.76%
Black Diamond Therapeutics
Oct 16, 2025
Reinstates: Buy
Price Target: $8
Current: $2.92
Upside: +173.97%
Cogent Biosciences
Oct 16, 2025
Initiates: Hold
Price Target: $16
Current: $36.61
Upside: -56.29%
Nkarta
Aug 14, 2024
Upgrades: Strong Buy
Price Target: $16
Current: $2.83
Upside: +465.37%